Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419).
|
J Med Chem
|
2007
|
0.91
|
2
|
Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase.
|
Bioorg Med Chem Lett
|
2002
|
0.83
|
3
|
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.
|
J Med Chem
|
2002
|
0.83
|
4
|
A survey of cyclic replacements for the central diamide moiety of inhibitors of inosine monophosphate dehydrogenase.
|
Bioorg Med Chem Lett
|
2002
|
0.80
|
5
|
Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56(Lck).
|
Bioorg Med Chem Lett
|
2002
|
0.80
|
6
|
The TosMIC approach to 3-(oxazol-5-yl) indoles: application to the synthesis of indole-based IMPDH inhibitors.
|
Bioorg Med Chem Lett
|
2002
|
0.77
|
7
|
Novel inhibitors of IMPDH: a highly potent and selective quinolone-based series.
|
Bioorg Med Chem Lett
|
2003
|
0.77
|
8
|
Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3.
|
Bioorg Med Chem Lett
|
2003
|
0.77
|
9
|
Novel amide-based inhibitors of inosine 5'-monophosphate dehydrogenase.
|
Bioorg Med Chem Lett
|
2002
|
0.77
|
10
|
Quinolone-based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analogues.
|
Bioorg Med Chem Lett
|
2003
|
0.77
|
11
|
Novel diamide-based inhibitors of IMPDH.
|
Bioorg Med Chem Lett
|
2002
|
0.77
|
12
|
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.
|
Bioorg Med Chem Lett
|
2005
|
0.76
|
13
|
Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity.
|
J Med Chem
|
2004
|
0.76
|
14
|
Identification of novel and potent isoquinoline aminooxazole-based IMPDH inhibitors.
|
Bioorg Med Chem Lett
|
2003
|
0.76
|
15
|
3-cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.
|
Bioorg Med Chem Lett
|
2003
|
0.76
|
16
|
Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist of leukocyte function associated antigen-1.
|
J Med Chem
|
2006
|
0.76
|
17
|
Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potency.
|
Bioorg Med Chem Lett
|
2002
|
0.75
|
18
|
A modified approach to 2-(N-aryl)-1,3-oxazoles: application to the synthesis of the IMPDH inhibitor BMS-337197 and analogues.
|
Org Lett
|
2002
|
0.75
|